All articles tagged with #injectable medications
A Cleveland Clinic study found that in real-world settings, injectable obesity medications semaglutide and tirzepatide lead to smaller weight loss compared to clinical trials, mainly due to treatment discontinuation and lower dosages, with discontinuation also negatively impacting blood sugar control in prediabetic patients.
A Cleveland Clinic study found that injectable obesity medications semaglutide and tirzepatide lead to smaller weight loss in real-world settings due to treatment discontinuation and lower dosages, with continued treatment and higher doses associated with greater weight loss and better blood sugar control, especially in patients with pre-diabetes.
Injectable weight loss medications like Wegovy and Ozempic are becoming popular among Floridians, with many displaying their weight loss on social media. However, these drugs are intended for diabetes and obesity and come with risks such as digestive issues, thyroid cancer, and suicidal behavior. They are also expensive and not covered by insurance for weight loss purposes. Doctors warn that these drugs should be used as part of a weight-loss effort that includes healthy eating and exercise, and caution against using off-brand versions.
Injectable medications like Ozempic, originally FDA-approved as a diabetes drug, have become a popular weight loss trend. The medication helps users lose a significant amount of weight by reducing appetite and slowing stomach emptying. While experts believe the shots are safer than older diet drugs or invasive bariatric surgery, they caution that they should be used under the care of a trained professional with a healthy diet and exercise. The shots are designed for people with a BMI of greater than 30 or a BMI of 27+ with a weight-related health issue. The cost of the medication is around $1,200 for a one-month supply, and it is not covered by insurance for weight loss purposes about 80% of the time.
Injectable medications like Ozempic, Wegovy, and Mounjaro are being used by millions of people for weight loss. Dr. Todd Ellerin, acting chief of medicine at South Shore Health, addresses concerns about the safety of these diabetes drugs.